Medical nutrition therapy is one of the cornerstones of diabetes management \[[@B1]\]. Evidence from prospective cohort studies and clinical trials has shown the importance of individual nutrients and foods for diabetes prevention and management \[[@B2], [@B3]\], but the overall effect of diet in achieving the recommended therapeutic targets has not been fully elucidated \[[@B1]\].

Eating patterns are defined as the quantities, proportions, variety, or combinations of different foods and beverages in diets, and the frequency with which they are habitually consumed \[[@B4]\]. The identification of eating patterns can be useful to investigate the relationship between diet and disease, especially when more than one dietary component (nutrients or foods) seem to be involved, as in diabetes \[[@B5]\]. This evaluation can be analyzed in two ways: *a priori*, eating patterns are defined based on guidelines and nutritional recommendations, or *a posteriori*, when data from dietary surveys are aggregated through specific statistical analysis \[[@B6], [@B7]\].

Several eating patterns defined *a priori* such as Mediterranean, low glycemic index, moderately low carbohydrate, or vegetarian diets have been recommended for the management of weight and glucose control in diabetes \[[@B1], [@B8]\]. However, recently the American Diabetes Association stated that there is no single ideal dietary distribution of calories from carbohydrates, fats, and protein for diabetes patients \[[@B1]\]. In this context, the choice of eating pattern should be individualized, taking into account the patient's current consumption preferences and the goal of metabolic targets \[[@B1], [@B9]\].

The aim of this cross-sectional study was to evaluate the relationship between eating patterns defined *a posteriori* and achieving recommended therapeutic targets (blood pressure, body weight, glycemic control, and lipid profile) in patients with type 2 diabetes in Southern Brazil.

1. Materials and Methods {#s5}
========================

A. Patients {#s6}
-----------

The current study was conducted in patients with type 2 diabetes, defined as individuals \>30 years of age at onset of diabetes, with no previous episode of ketoacidosis or documented ketonuria and who had not been using insulin in the 5 years since the diabetes was diagnosed \[[@B10]\]. The study recruited outpatients who consecutively attended the Endocrinology Division of the Hospital de Clínicas de Porto Alegre, Brazil.

The inclusion criteria were: age, \<80 years; serum creatinine, \<2.0 mg/dL; and body mass index (BMI), \<40 kg/m^2^. Patients on corticosteroid treatment or who had orthostatic hypotension or gastrointestinal symptoms suggestive of autonomic neuropathy were excluded. This study was conducted according to the guidelines laid down in the Declaration of Helsinki, and all procedures involving patients were approved by the Ethics Committee of the Hospital de Clínicas de Porto Alegre, Brazil. Written informed consent was obtained from all patients.

B. Clinical and Laboratory Evaluation {#s7}
-------------------------------------

Patients were submitted to clinical, laboratory, and lifestyle evaluation. Information about clinical data (comorbidities associated with diabetes and medication use) was collected from the patient's most recent medical records. Blood pressure was measured twice (Omron HEM-705CP) according to international recommendations \[[@B11]\]. Increased urinary albumin excretion (UAE) was considered in the presence of UAE ≥ 14 mg/L in a random spot urine collection, or ≥30 mg in 24-hour collection, and the diagnosis was always confirmed \[[@B1], [@B12]\]. Patients were classified as current smokers or not (former and nonsmokers) and self-identified as white or nonwhite. Economic status was evaluated by a standardized Brazilian questionnaire \[[@B13]\], and physical activity level was classified according to the short version of the International Physical Activity Questionnaire \[[@B14]\] culturally adapted to the Brazilian population \[[@B15]\]. Physical activity was graded at three levels, that is, low, moderate, and high, according to activities during a typical week \[[@B14]\].

Blood samples were obtained after a 12-hour fast. Serum creatinine level was determined by a Jaffe reaction and estimated glomerular filtration rate by the Study Group and the Chronic Kidney Disease Epidemiology Collaboration Calculator. Plasma glucose was measured by a glucose oxidase method, hemoglobin A1c (HbA1c) was assessed by high-performance liquid chromatography (Tosoh 2.2 Plus HbA1c; Tosoh Corporation, Tokyo, Japan; reference values 4.8% to 6%), total cholesterol and triglycerides were measured by enzymatic-colorimetric methods, and high-density lipoprotein (HDL) cholesterol was measured by a homogeneous direct method. Low-density lipoprotein (LDL) cholesterol was calculated using the Friedewald's formula, that is, LDL cholesterol = total cholesterol − HDL cholesterol − (triglycerides/5) \[[@B16]\] only for patients with triglyceride values \< 400 mg/dL. UAE was measured by immunoturbidimetry \[MicroAlb Sera-Pak immuno microalbuminuria (Bayer, Tarrytown, NY) on Cobas Mira Plus (Roche)\].

C. Nutritional Evaluation: Anthropometric and Dietary Assessments {#s8}
-----------------------------------------------------------------

The body weight and height of patients (light clothing and without shoes) were obtained with measurements recorded to the nearest 100 g for weight and to the nearest 0.1 cm for height. BMI was then calculated. Waist circumference was measured at the midpoint between the iliac crest and the last floating rib. A flexible and nonstretch fiberglass tape was used for this measurement.

Information on food intake was collected from a quantitative food frequency questionnaire (FFQ) previously constructed \[[@B17]\] and validated \[[@B18]\] in patients from Southern Brazil. The FFQ consist of 98 food items and covered the past 12 months of food intake. Also, a portfolio with photographs of each food item and its portion sizes was used to support patients in identifying the consumed portion.

The intake report obtained by the FFQ was converted into daily consumption to estimate the nutritional composition \[[@B19]--[@B21]\]. The glycemic index and load were obtained from the international table \[[@B22]\]. When the glycemic index of foods present in the instruments was not found, we used data from food with a similar composition. Calculations were performed using the syntax of the SPSS version 20.0 program (SPSS, Chicago, IL).

D. Therapeutic Target Definitions {#s9}
---------------------------------

Patients were considered to be within the therapeutic target according to the following criteria: systolic/diastolic blood pressure, \<140/90 mm Hg; BMI, \<25 kg/m^2^ or \<27 kg/m^2^ for the elderly \[[@B1], [@B23]\]; waist circumference, \<94 cm for men and \<80 cm for women \[[@B24]\]; fasting plasma glucose, \<130 mg/dL; HbA1c values \< 7%; serum triglycerides \< 150 mg/dL; HDL cholesterol, \>40 mg/dL for men and \>50 mg/dL for women; and LDL cholesterol, \<100 mg/dL \[[@B1]\].

E. Statistical Analysis {#s10}
-----------------------

The FFQ foods were aggregated into 18 groups and the amount consumed from each food group was converted into a percentage of total daily caloric intake. We performed a cluster analysis based on food groups to derive two nonoverlapping groups (eating patterns) using the K-means method. Median and interquartile range were calculated for each of the 18 food groups and compared by a Mann--Whitney *U* test for independent samples.

We examined the assumption of normality for all evaluated variables by a Kolmogorov--Smirnov test. A *χ*^2^ test, Student *t* test, and Mann--Whitney test for independent samples were used to test differences across the eating patterns. Energy and nutrient intake data were adjusted before analyses for energy intake according to the residual method \[[@B5]\].

To investigate the associations between eating patterns and achieve therapeutic targets we used Poisson regression with robust variance analysis. As the first step of the analysis, we estimated the effect of eating patterns on each therapeutic target (dependent variable). The second analysis (model 1) was adjusted for sex, age, economic status, current smoking, and diabetes duration. The third analysis (model 2) was additionally adjusted for diabetes treatment, physical activity, BMI, and energy intake. BMI was not included as covariate in the analysis of body weight and waist circumference targets (model 3).

Analyses were performed using SPSS version 20.0 (SPSS) and the type I error rate was fixed at *P* ≤ 0.05 (2-tailed).

2. Results {#s11}
==========

Our sample consisted of 197 patients with type 2 diabetes: women, 63.5%; white, 70.6%; age, 62.5 ± 9.1 years; diabetes duration, 10 (5 to 19) years; BMI, 30.9 ± 4.3 kg/m^2^; presence of hypertension, 89.8%; presence of increased UAE, 39.1%; HbA1c, 8.5% ± 2.0%; and fasting plasma glucose, 164.7 ± 68.2 mg/dL.

We identified two eating patterns regarding quality of food groups consumed based on cluster analysis. The first cluster, defined as a "healthy" eating pattern (n = 97), had a high intake of whole carbohydrates, dairy, white meat, fish, fruits, and vegetables (*P* \< 0.05). The second cluster identified was defined as an "unhealthy" eating pattern (n = 100) and was characterized by high consumption of refined carbohydrates, ultraprocessed foods, sweets, and desserts (*P* \< 0.05).

The medians and interquartile ranges of food group consumption (converted into a percentages of daily caloric intake) according to eating patterns are described in [Table 1](#T1){ref-type="table"}. We observed a median of 0 in two food groups, that is, alcoholic beverages and fish, although the fish consumption was different between groups: 67% of patients reported no consumption of fish in the unhealthy cluster and 49.5% in the healthy cluster (*P* = 0.01). Regarding consumption of alcoholic beverages, 59% of patients in the unhealthy cluster and 67% of patients in the healthy cluster reported no consumption (*P* = 0.24).

###### 

**Daily Consumption of Food Groups in Patients With Type 2 Diabetes According to Eating Patterns**

  **Food Groups (% of Total Caloric Intake)**   **Eating Patterns**   ***P* Value**       
  --------------------------------------------- --------------------- ------------------- -------
  Whole carbohydrates                           0.0 (0.0--2.4)        10.1 (3.5--17.5)    0.001
  Refined carbohydrates                         32.3 (27.6--38.5)     14.9 (10.7--18.4)   0.001
  Fried foods                                   1.5 (0.1--5.2)        0.9 (0.0--4.3)      0.450
  Ultraprocessed foods                          2.7 (1.0--4.5)        1.4 (0.2--2.6)      0.001
  Dairy                                         8.0 (3.9--11.7)       11.0 (7.4--16.1)    0.001
  Light and diet foods                          0.0 (0.0--1.3)        0.4 (0.0--3.1)      0.198
  Caffeinated beverages                         0.9 (0.4--1.8)        1.0 (0.5--1.7)      0.919
  Alcoholic beverages                           0.0 (0.0--0.3)        0.0 (0.0--0.4)      0.633
  Sweets and desserts                           3.2 (0.5--7.2)        2.1 (0.3--4.7)      0.032
  Red meat                                      10.0 (6.1--13.6)      11.4 (6.1--14.8)    0.217
  White meat                                    4.3 (2.5--6.9)        5.6 (3.4--8.2)      0.009
  Fish                                          0.0 (0.0--0.1)        0.0 (0.0--1.4)      0.035
  Fruits                                        12.4 (7.7--16.3)      16.7 (12.5--21.6)   0.001
  Vegetables                                    2.3 (1.5--3.6)        3.5 (2.5--5.7)      0.001
  Beans                                         3.3 (1.7--4.9)        3.2 (1.5--4.5)      0.919
  Natural juices                                0.1 (0.0--1.4)        0.2 (0.0--1.5)      0.612
  Solid fats                                    0.4 (0.0--1.5)        0.8 (0.0--1.5)      0.497
  Vegetable oils                                2.2 (1.3--4.9)        2.5 (0.6--4.6)      0.218

Data are expressed as median (interquartile range). *P* values were determined by a Mann--Whitney *U* test.

The nutrient intake according to eating pattern is shown in [Table 2](#T2){ref-type="table"}. Differences in nutrient intake were in accordance with results of cluster analyses. Patients from the healthy eating pattern had significantly lower energy, *trans-*unsaturated fatty acid, and sodium intakes than did those in the unhealthy eating pattern (*P* \< 0.05). The healthy group consumed a diet with a lower index and glycemic load (*P* \< 0.05) than did the unhealthy group. The intake of protein, total, soluble, and insoluble fiber, omega-3 fatty acid, calcium, magnesium, iron, potassium, and vitamin C were highest in patients from the healthy eating pattern (*P* \< 0.05).

###### 

**Daily Energy Intake, Macronutrients and Micronutrients, Fiber, Glycemic Index, and Glycemic Load in Patients With Type 2 Diabetes According to Eating Patterns**

  **Nutrients**                                                          **Eating Patterns**    ***P* Value**          
  ---------------------------------------------------------------------- ---------------------- ---------------------- ------------------------------------------
  Energy, kcal                                                           2005.6 ± 788.5         1757.0 ± 649.3         0.017[*^a^*](#t2n1){ref-type="table-fn"}
  Protein, g[*^b^*](#t2n2){ref-type="table-fn"}                          84.3 ± 19.0            94.1 ± 15.3            0.001[*^a^*](#t2n1){ref-type="table-fn"}
  Carbohydrate, g[*^b^*](#t2n2){ref-type="table-fn"}                     268.8 ± 42.4           257.7 ± 42.8           0.068[*^a^*](#t2n1){ref-type="table-fn"}
  Total fiber, g[*^b^*](#t2n2){ref-type="table-fn"}                      25.0 ± 7.1             30.7 ± 9.9             0.001[*^a^*](#t2n1){ref-type="table-fn"}
  Soluble fiber, g[*^b^*](#t2n2){ref-type="table-fn"}                    7.0 ± 2.1              8.4 ± 2.8              0.001[*^a^*](#t2n1){ref-type="table-fn"}
  Insoluble fiber, g[*^b^*](#t2n2){ref-type="table-fn"}                  16.8 ± 5.3             20.4 ± 7.5             0.001[*^a^*](#t2n1){ref-type="table-fn"}
  Total lipids, g[*^b^*](#t2n2){ref-type="table-fn"}                     53.8 ± 13.4            56.4 ± 13.2            0.178[*^a^*](#t2n1){ref-type="table-fn"}
  Saturated fatty acid, g[*^b^*](#t2n2){ref-type="table-fn"}             19.0 ± 5.7             20.2 ± 5.6             0.157[*^a^*](#t2n1){ref-type="table-fn"}
  Monounsaturated fatty acid (g)[*^b^*](#t2n2){ref-type="table-fn"}      17.4 ± 4.9             18.3 ± 5.3             0.247[*^a^*](#t2n1){ref-type="table-fn"}
  Polyunsaturated fatty acid, g[*^b^*](#t2n2){ref-type="table-fn"}       8.8 ± 3.5              9.4 ± 3.2              0.241[*^a^*](#t2n1){ref-type="table-fn"}
  Omega-3 fatty acid, g[*^b^*](#t2n2){ref-type="table-fn"}               0.7 ± 0.3              0.8 ± 0.3              0.006[*^a^*](#t2n1){ref-type="table-fn"}
  Omega-6 fatty acid, g[*^b^*](#t2n2){ref-type="table-fn"}               6.9 ± 3.1              7.4 ± 2.8              0.282[*^a^*](#t2n1){ref-type="table-fn"}
  *Trans*-unsaturated fatty acid, g[*^b^*](#t2n2){ref-type="table-fn"}   1.6 (1.1--2.4)         1.3 (1.0--1.7)         0.001[*^c^*](#t2n3){ref-type="table-fn"}
  Cholesterol, mg[*^b^*](#t2n2){ref-type="table-fn"}                     248.5 ± 97.4           271.7 ± 88.4           0.082[*^a^*](#t2n1){ref-type="table-fn"}
  Calcium, mg[*^b^*](#t2n2){ref-type="table-fn"}                         751.9 ± 302.7          992.8 ± 358.5          0.001[*^a^*](#t2n1){ref-type="table-fn"}
  Magnesium, mg[*^b^*](#t2n2){ref-type="table-fn"}                       268.5 ± 54.9           333.3 ± 67.7           0.001[*^a^*](#t2n1){ref-type="table-fn"}
  Iron, mg[*^b^*](#t2n2){ref-type="table-fn"}                            9.0 ± 2.2              10.2 ± 2.0             0.001[*^a^*](#t2n1){ref-type="table-fn"}
  Sodium, mg[*^b^*](#t2n2){ref-type="table-fn"}                          1584.2 ± 472.4         1356.5 ± 341.1         0.001[*^a^*](#t2n1){ref-type="table-fn"}
  Potassium, mg[*^b^*](#t2n2){ref-type="table-fn"}                       3124.9 ± 710.0         3738.3 ± 608.0         0.001[*^a^*](#t2n1){ref-type="table-fn"}
  Vitamin C, mg[*^b^*](#t2n2){ref-type="table-fn"}                       190.6 (124.8--297.7)   250.4 (195.3--350.7)   0.001[*^c^*](#t2n3){ref-type="table-fn"}
  Glycemic index, %[*^b^*](#t2n2){ref-type="table-fn"}                   50.0 ± 5.6             43.7 ± 5.0             0.001[*^a^*](#t2n1){ref-type="table-fn"}
  Glycemic load, g[*^b^*](#t2n2){ref-type="table-fn"}                    134.3 ± 32.2           113.1 ± 24.7           0.001[*^a^*](#t2n1){ref-type="table-fn"}

Data are expressed as means ± standard deviation or median (interquartile range).

Student *t* test for independent samples.

Data adjusted for energy intake according to the residuals method.

Mann--Whitney *U* test.

Clinical and laboratory characteristics of the eating patterns are shown in [Table 3](#T3){ref-type="table"}. Most clinical and laboratory features did not differ between groups, but there were more women in the healthy group (71.1% *vs* 56.0%; *P* = 0.038), were older (63.9 ± 9.1 years *vs* 61.1 ± 9.0 years; *P* = 0.028), and had lower fasting plasma glucose (150.2 ± 61.5 mg/dL *vs* 179.1 ± 71.1 mg/dL; *P* = 0.003) than did the unhealthy group. Men from the healthy group have a smaller waist circumference (102.7 ± 9.3 cm *vs* 107.9 ± 11.4 cm; *P* = 0.048) than do men from the unhealthy group.

###### 

**Clinical and Laboratory Characteristics of Patients With Type 2 Diabetes According to Eating Patterns**

  **Characteristics**                   **Eating Patterns**    ***P* Value**         
  ------------------------------------- ---------------------- --------------------- ------------------------------------------
  Females                               56 (56.0)              69 (71.1)             0.038[*^a^*](#t3n1){ref-type="table-fn"}
  Age, y                                61.1 ± 9.0             63.9 ± 9.1            0.028[*^b^*](#t3n2){ref-type="table-fn"}
  Whites                                65 (65.0)              74 (76.3)             0.088[*^a^*](#t3n1){ref-type="table-fn"}
  Years of study                        6.5 (4.0--11.0)        6.0 (4.0--11.0)       0.729[*^c^*](#t3n3){ref-type="table-fn"}
  Economic status: middle class         43 (45.3)              48 (51.7)             0.449[*^a^*](#t3n1){ref-type="table-fn"}
  Current smoking                       20 (20.0)              8 (8.2)               0.060[*^a^*](#t3n1){ref-type="table-fn"}
  Physical activity: low level          59 (60.8)              61 (64.9)             0.568[*^a^*](#t3n1){ref-type="table-fn"}
  Diabetes duration, y                  10.0 (4.0--17.7)       10.0 (5.0--19.5)      0.635[*^c^*](#t3n3){ref-type="table-fn"}
  Hypertension                          89 (89.0)              88 (90.7)             0.815[*^a^*](#t3n1){ref-type="table-fn"}
  Systolic blood pressure, mmHg         143.3 ± 26.2           140.3 ± 17.8          0.351[*^b^*](#t3n2){ref-type="table-fn"}
  Diastolic blood pressure, mmHg        78.3 ± 13.1            76.9 ± 10.0           0.403[*^b^*](#t3n2){ref-type="table-fn"}
  Increased UAE                         41 (41.0)              31 (31.9)             0.228[*^a^*](#t3n1){ref-type="table-fn"}
  Diabetes treatment                                                                 
  Diet                                  1 (1.0)                4 (4.1)               0.350[*^a^*](#t3n1){ref-type="table-fn"}
  Oral hypoglycemic drugs               42 (42.0)              46 (47.4)             
  Insulin and oral hypoglycemic drugs   50 (50.0)              43 (44.3)             
  Antihypertensive drugs, number        2.0 (1.0--4.0)         2.0 (2.0--3.0)        0.892[*^c^*](#t3n3){ref-type="table-fn"}
  Use of ACE inhibitor                  68 (68.0)              56 (57.7)             0.143[*^a^*](#t3n1){ref-type="table-fn"}
  Use of lipid-lowering drugs           71 (71.0)              64 (66.0)             0.448[*^a^*](#t3n1){ref-type="table-fn"}
  Previous cardiovascular event         31 (31.0)              25 (25.8)             0.384[*^a^*](#t3n1){ref-type="table-fn"}
  BMI, kg/m^2^                          31.4 ± 4.6             30.4 ± 3.9            0.098[*^b^*](#t3n2){ref-type="table-fn"}
  Waist circumference, cm                                                            
  Male                                  107.9 ± 11.4           102.7 ± 9.3           0.048[*^b^*](#t3n2){ref-type="table-fn"}
  Female                                103.6 ± 11.1           102.2 ± 8.6           0.442[*^b^*](#t3n2){ref-type="table-fn"}
  Fasting plasma glucose, mg/dL         179.0 ± 71.1           150.2 ± 61.5          0.003[*^b^*](#t3n2){ref-type="table-fn"}
  HbA1c, %                              8.7 ± 2.0              8.3 ± 2.0             0.230[*^b^*](#t3n2){ref-type="table-fn"}
  Total cholesterol, mg/dL              179.1 ± 37.1           171.4 ± 41.8          0.195[*^b^*](#t3n2){ref-type="table-fn"}
  HDL cholesterol, mg/dL                                                             
  Male                                  40.3 ± 11.1            39.5 ± 9.6            0.786[*^b^*](#t3n2){ref-type="table-fn"}
  Female                                43.6 ± 9.0             43.8 ± 12.0           0.907[*^b^*](#t3n2){ref-type="table-fn"}
  LDL cholesterol, mg/dL                105.0 ± 32.9           97.3 ± 34.4           0.131[*^b^*](#t3n2){ref-type="table-fn"}
  Triglyceride, mg/dL                   150.0 (106.0--198.5)   131.0 (98.0--197.0)   0.405[*^c^*](#t3n3){ref-type="table-fn"}
  Serum creatinine, mg/dL               0.9 ± 0.3              0.8 ± 0.3             0.806[*^b^*](#t3n2){ref-type="table-fn"}
  GFR, mL/min/1.73 m^2^                 84.9 ± 18.5            81.5 ± 21.4           0.247[*^b^*](#t3n2){ref-type="table-fn"}
  UAE, mg/dL                            11.1 (3.8--48.1)       5.6 (3.0--27.0)       0.070[*^c^*](#t3n3){ref-type="table-fn"}

Data are expressed as means ± standard deviation, median (interquartile range), or number of patients with the analyzed characteristic (%).

Abbreviation: GFR, glomerular filtration rate.

*χ*^2^ Test.

Student *t* test.

Mann--Whitney *U* test.

Results comparing the proportion of patients who achieved therapeutic targets in healthy and unhealthy groups are depicted in [Table 4](#T4){ref-type="table"}. A larger proportion of patients who maintained a healthy eating pattern achieved fasting plasma glucose values \< 130 mg/dL (47.4% *vs* 31.3%; *P* = 0.028), HbA1c \< 7% (33.0% *vs* 17.0%; *P* = 0.013), and LDL cholesterol \< 100 mg/dL (63.2% *vs* 46.6%; *P* = 0.034). There were no differences between groups in the evaluation of other therapeutic targets (blood pressure, BMI, waist circumference, HDL cholesterol, and triglycerides).

###### 

**Proportion of Patients With Type 2 Diabetes Who Achieve Therapeutic Targets According to Eating Patterns**

  **Therapeutic Targets**                                    **Eating Patterns**   ***P* value**       
  ---------------------------------------------------------- --------------------- ------------------- ------------------------------------------
  Blood pressure, n (%)                                      50 (50.5)             49 (52.1)           0.822[*^a^*](#t4n1){ref-type="table-fn"}
   PR (95% CI)                                               1                     1.03 (0.78--1.36)   0.822
   PR adjusted[*^b^*](#t4n2){ref-type="table-fn"} (95% CI)   1                     1.08 (0.80--1.45)   0.628
   PR adjusted[*^c^*](#t4n3){ref-type="table-fn"} (95% CI)   1                     1.07 (0.78--1.47)   0.663
  BMI, n (%)                                                 16 (16.0)             14 (14.4)           0.844[*^a^*](#t4n1){ref-type="table-fn"}
   PR (95% CI)                                               1                     0.90 (0.47--1.75)   0.760
   PR adjusted[*^b^*](#t4n2){ref-type="table-fn"} (95% CI)   1                     1.08 (0.48--2.44)   0.844
   PR adjusted[*^d^*](#t4n4){ref-type="table-fn"} (95% CI)   1                     1.07 (0.49--2.36)   0.859
  Waist circumference, n (%)                                 8 (8.0)               6 (6.2)             0.783[*^a^*](#t4n1){ref-type="table-fn"}
   PR (95% CI)                                               1                     0.77 (0.28--2.15)   0.621
   PR adjusted[*^b^*](#t4n2){ref-type="table-fn"} (95% CI)   1                     1.40 (0.47--4.17)   0.551
   PR adjusted[*^d^*](#t4n4){ref-type="table-fn"} (95% CI)   1                     0.93 (0.26--3.27)   0.905
  Fasting plasma glucose, n (%)                              31 (31.3)             46 (47.4)           0.028[*^a^*](#t4n1){ref-type="table-fn"}
   PR (95% CI)                                               1                     1.51 (1.06--2.17)   0.024
   PR adjusted[*^b^*](#t4n2){ref-type="table-fn"} (95% CI)   1                     1.59 (1.01--2.34)   0.018
   PR adjusted[*^c^*](#t4n3){ref-type="table-fn"} (95% CI)   1                     1.47 (0.98--2.19)   0.060
  HbA1c, n (%)                                               17 (17.0)             32 (33.0)           0.013[*^a^*](#t4n1){ref-type="table-fn"}
   PR (95% CI)                                               1                     1.94 (1.16--3.26)   0.012
   PR adjusted[*^b^*](#t4n2){ref-type="table-fn"} (95% CI)   1                     2.61 (1.51--4.53)   0.001
   PR adjusted[*^c^*](#t4n3){ref-type="table-fn"} (95% CI)   1                     2.09 (1.17--3.74)   0.013
  Triglycerides, n (%)                                       43 (48.3)             48 (55.2)           0.371[*^a^*](#t4n1){ref-type="table-fn"}
   PR (95% CI)                                               1                     1.14 (0.86--1.52)   0.364
   PR adjusted[*^b^*](#t4n2){ref-type="table-fn"} (95% CI)   1                     1.15 (0.86--1.53)   0.344
   PR adjusted[*^c^*](#t4n3){ref-type="table-fn"} (95% CI)   1                     1.11 (0.82--1.50)   0.501
  HDL cholesterol, n (%)                                     27 (30.3)             25 (28.4)           0.869[*^a^*](#t4n1){ref-type="table-fn"}
   PR (95% CI)                                               1                     0.94 (0.59--1.48)   0.778
   PR adjusted[*^b^*](#t4n2){ref-type="table-fn"} (95% CI)   1                     0.91 (0.59--1.40)   0.663
   PR adjusted[*^c^*](#t4n3){ref-type="table-fn"} (95% CI)   1                     0.81 (0.51--1.30)   0.387
  LDL cholesterol, n (%)                                     41 (46.6)             55 (63.2)           0.034[*^a^*](#t4n1){ref-type="table-fn"}
   PR (95% CI)                                               1                     1.36 (1.03--1.79)   0.030
   PR adjusted[*^b^*](#t4n2){ref-type="table-fn"} (95% CI)   1                     1.32 (1.00--1.74)   0.052
   PR adjusted[*^c^*](#t4n3){ref-type="table-fn"} (95% CI)   1                     1.37 (1.01--1.86)   0.042

Data are expressed as number of patients with analyzed characteristic (%) and as the PR (95% CI). Therapeutic target definitions are: blood pressure. \<140/90 mm Hg; BMI, \<25 kg/m^2^ or \<27 kg/m^2^ for the elderly; waist circumference, \<94 cm for men and \<80 cm for women; fasting plasma glucose, \<130 mg/dL; HbA1c, \<7%; serum triglycerides, \<150 mg/dL; HDL cholesterol, \>40 mg/dL for men and \>50 mg/dL for women; LDL cholesterol, \<100 mg/dL.

*χ*^2^ Test.

Model 1: adjusted for sex, age, economic status, current smoking, and diabetes duration.

Model 3: adjusted for sex, age, economic status, current smoking, diabetes duration, diabetes treatment, physical activity, and energy intake.

Model 2: adjusted for sex, age, economic status, current smoking, diabetes duration, diabetes treatment, physical activity, BMI, and energy intake.

In the crude analysis of Poisson regression, it was observed that the healthy eating pattern was associated with achieving the therapeutic targets for fasting plasma glucose \[prevalence ratio (PR), 1.51; 95% CI, 1.06 to 2.17\], HbA1c (PR, 1.94; 95% CI 1.16 to 3.26), and LDL cholesterol (PR, 1.36; 95% CI, 1.03 to 1.79). In model 1, these associations were confirmed for fasting plasma glucose (PR, 1.59; 95% CI, 1.01 to 2.34), and HbA1c (PR, 2.61; 95% CI, 1.51 to 4.53). In models 2 and 3, HbA1c (PR, 2.09; 95% CI, 1.17 to 3.74), and LDL cholesterol (PR, 1.37; 95% CI, 1.01 to 1.86) were the target variables associated with a healthy eating pattern ([Table 4](#T4){ref-type="table"}).

3. Discussion {#s12}
=============

In this cross-sectional study, we obtained data from 197 patients with type 2 diabetes and identified two eating patterns by cluster analysis. The healthy eating pattern, characterized by high consumption of whole carbohydrates, dairy, white meat, fish, fruits, and vegetables, was associated with better glycemic and lipid control than the unhealthy eating pattern. Patients in the healthy eating pattern had lower fasting plasma glucose, HbA1c, and LDL cholesterol and most frequently reached the recommended therapeutic targets for these parameters as compared with patients from the unhealthy eating pattern. As expected, patients in the healthy group had a higher intake of protein, total, soluble, and insoluble fiber, omega-3 fatty acid, calcium, magnesium, iron, potassium, and vitamin C. Moreover, the association between the healthy eating pattern and achieving the therapeutic targets for fasting plasma glucose, HbA1c, and LDL cholesterol remained, even when potential confounding factors were taken into account as demonstrated by regression analyses.

It is known that carbohydrates are the nutrients that most affect blood glucose levels. However, up to now there is no consensus evidence about the ideal amount of carbohydrate intake for people with diabetes \[[@B1], [@B9]\]. In fact, in the present study, the carbohydrate consumption did not differ between the unhealthy and healthy group. The association between healthy eating pattern and glycemic control could be better explained by the quality of carbohydrate intake than the amount of this macronutrient. In agreement with this, we demonstrated a higher consumption of whole carbohydrates, fruits, and vegetables in this group of patients. As a consequence, these patients consumed diets with a lower glycemic index and glycemic load values as compared with patients in the unhealthy eating pattern. Currently, diets with a low glycemic index have been associated with improved glycemic control \[[@B25]\].

Another nutrient probably related to the best observed glycemic control in our study is dietary fiber. Accordingly, in our patients in the healthy eating pattern, a higher total, soluble, and insoluble fiber consumption was observed. It has already been demonstrated that a high fiber intake was associated with better glycemic control in patients with diabetes \[[@B26], [@B27]\]. However, up to now, the beneficial effects of fiber intake, especially soluble fibers, could not be isolated from the effects of glycemic index and glycemic load because most foods that have a low glycemic index also have a high fiber content \[[@B8]\].

Alternatively, the better lipid profile observed in patients in the healthy eating pattern, as compared with the unhealthy eating pattern, was, at least partially, due to dietary fiber content. A beneficial fiber effect on the lipid profile \[[@B28]\] with reduction of total and LDL cholesterol and triglycerides \[[@B29], [@B30]\] had already been previously established. In our study, a higher proportion of patients in the healthy group (rich in fibers) had LDL cholesterol \<100 mg/dL as compared with patients in the unhealthy group. This result could not be explained by lipid-lowering drugs because the frequency of drug users was not different in healthy and unhealthy groups, nor were BMI and the level of physical activity.

Fat consumption, along with fiber intake, could have influenced the improvement of LDL cholesterol in a healthy eating pattern. The dietary cholesterol and the saturated fatty acid intake did not differ between healthy and unhealthy groups. However, the *trans-*unsaturated fatty acids intake was lower in patients in the healthy group. In fact, this dietary component was already associated with high LDL cholesterol levels \[[@B31]\].

Although our study has a cross-section design that allowed us to describe only possible associations, it is worthwhile observing that the healthy eating pattern identified in the present study presents similarities with the Dietary Approaches to Stop Hypertension diet, which is an *a priori* eating pattern characterized by high consumption of vegetables, fruits, low-fat dairy products, whole grains, poultry, and fish and is low in sweets and desserts \[[@B32], [@B33]\]. In fact, the beneficial effect of this dietary pattern has already been demonstrated in short-term trials in patients with diabetes \[[@B34]--[@B36]\].

The association between eating patterns defined *a posteriori* and health outcomes in individuals with diabetes has been studied more recently in different countries. However, most of these studies, different from ours, used factor analysis to determine eating patterns \[[@B37]--[@B44]\]. To our knowledge, our study was the first to use cluster analysis, a method that creates patterns that are mutually exclusive (*i.e.*, categorical variables) and that are defined by maximizing differences in mean intake of food groups \[[@B6]\]. Cluster analysis findings are easier to interpret because an individual is in one cluster only, outcomes are specific to individuals within each cluster, and each cluster has a specific food and nutrient composition \[[@B45]\].

Moreover, in our study, some methodological precautions were also taken into account. We used a food frequency questionnaire previously constructed \[[@B17]\] and validated \[[@B18]\] in patients from Southern Brazil, and the macronutrient and micronutrient data were adjusted for energy using the residual method \[[@B5]\]. Also, the sample size we used to analyze a food consumption tool was appropriately calculated \[[@B46]\]. We included 10 individuals for each food group studied (18 food groups studied and 180 subjects).

A possible limitation of our study was the absence of an actual sodium intake estimate. We used the intrinsic sodium of foods derived from a table \[[@B19]\] instead of measurements of 24-hour urinary sodium, a more accurate evaluation of salt consumption \[[@B47]\]. Finally, as expected, the adopted cross-sectional design hinders any causal inferences. The associations of healthy eating patterns as described in our study should be evaluated in different samples of patients with diabetes, in long-term cohorts, and, ideally, in randomized clinical trials. The recommendation of a healthy eating pattern, instead of prescribing allowed or forbidden foods, should be tested as a useful dietary strategy for patients with diabetes.

In conclusion, in patients with type 2 diabetes a healthy eating pattern including the frequent intake of whole carbohydrates, dairy, white meat, fish, fruits and vegetables was associated with lower fasting plasma glucose, HbA1c, and LDL cholesterol levels as compared with an eating pattern with high consumption of refined carbohydrates, ultraprocessed foods, sweets, and desserts.

Abbreviations: BMIbody mass indexCIconfidence intervalFFQfood frequency questionnaireHbA1chemoglobin A1cHDLhigh-density lipoproteinLDLlow-density lipoproteinPRprevalence ratioUAEurinary albumin excretion.
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